Product Information
CHOLESTYRAMINE PACKET is a generic product labeled by Zydus Pharmaceuticals (USA) Inc., priced at $0.7724 per EA under NDC 68382052860. Its NADAC has been published 395 times since Nov 7, 2018.
FDA first approved this application on Jul 2, 2018. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
4 g/9g
Manufacturer
Zydus Pharmaceuticals (USA) Inc.NDC
68382052860
Classification
Generic
Dosage Form
POWDER, FOR SUSPENSION
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
CHOLESTYRAMINEApproval Type
Generic (ANDA)
FDA Application
ANDA202901FDA Approved
7/2/2018
TE Code
AB
On Market Since
8/1/2018
Pharmacological Classes
Price Statistics
The NADAC for CHOLESTYRAMINE PACKET has been published 395 times since Nov 7, 2018, and over the history we have for it it has declined 46.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.7724 per EA |
|---|---|
| All-time high | $1.4925 (Jul 10, 2019) |
| All-time low | $0.5806 (Apr 17, 2024) |
| 52-week high | $0.9390 |
| 52-week low | $0.6721 |
| Median price | $1.0712 |
| Average price | $1.0686 |
| Largest weekly change | +34.2% (Jun 19, 2024) |
| Weeks tracked | 395 |
| Tracking since | Nov 7, 2018 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of CHOLESTYRAMINE PACKET?
The current National Average Drug Acquisition Cost (NADAC) for CHOLESTYRAMINE PACKET, manufactured by Zydus Pharmaceuticals (USA) Inc., is $0.7724 per EA (NDC 68382052860), effective Aug 19, 2026.
How has the price of CHOLESTYRAMINE PACKET changed over time?
Over the history we have for it, the NADAC for CHOLESTYRAMINE PACKET has declined 46.4%. It has been tracked across 395 weekly CMS publications since Nov 7, 2018.
What are the highest and lowest recorded NADAC prices for CHOLESTYRAMINE PACKET?
Since Nov 7, 2018, the NADAC for CHOLESTYRAMINE PACKET has ranged from a low of $0.5806 (Apr 17, 2024) to a high of $1.4925 (Jul 10, 2019), with a median of $1.0712 per EA.
Are there cheaper alternatives to CHOLESTYRAMINE PACKET?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as CHOLESTYRAMINE PACKET in a comparable dosage form, but none are currently priced below it.
Who manufactures CHOLESTYRAMINE PACKET?
CHOLESTYRAMINE PACKET (NDC 68382052860) is labeled by Zydus Pharmaceuticals (USA) Inc., and CMS classifies it as a generic product.